Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Cold Spring Harbor Perspectives in Medicine|November 5, 2014
Rhabdomyosarcoma: current challenges and their implications for developing therapiesSimone Hettmer, Zhizhong Li, Andrew N Billin, et al.
Cancers|March 13, 2024
Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)Julia Chisholm, Henry Mandeville, Madeleine Adams, et al.
Cancers|October 16, 2024
Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancers 2024, 16, 998Julia Chisholm, Henry Mandeville, Madeleine Adams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2011
Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapyRoberto Tonelli, Alan McIntyre, Consuelo Camerin, et al.
Nature Genetics|June 13, 2017
Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumorKevin Litchfield, Max Levy, Giulia Orlando, et al.
Scientific Reports|July 15, 2018
Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAnessHarriett Holme, Aditi Gulati, Rachel Brough, et al.
Scientific Reports|August 23, 2018
Author Correction: Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAnessHarriett Holme, Aditi Gulati, Rachel Brough, et al.
European Journal of Cancer (Oxford, England : 1990)|September 24, 2019
A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterationsSally L George, Elisa Izquierdo, James Campbell, et al.
Pediatric Blood & Cancer|June 22, 2019
Insights into pediatric rhabdomyosarcoma research: Challenges and goalsMarielle E Yohe, Christine M Heske, Elizabeth Stewart, et al.
JCO Precision Oncology|October 20, 2022
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility StudyOlivia Ruhen, Nathalie S M Lak, Janine Stutterheim, et al.
Pageof 11